Surveillance of Treatment of Children With Growth Hormone Deficiency With Zomacton®

• Status: Withdrawn
• Trial end date: 2018-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the long-term treatment with Zomacton® for pituitary short stature in children with insufficient growth hormone production and/or short stature caused by Turner's syndrome.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ferring Pharmaceuticals
• Treatments: Hormones

Criteria

Inclusion Criteria:

• therapeutic need according to the approved specific products characteristics (SPC)

Exclusion Criteria:

• contraindication according to the SPC